GPT and hepatotoxicity: Several adverse events of special interest (AESI) were reported, including nine hepatotoxicity events in seven children (21.9%), including one patient in the medium-dose cohort who experienced elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST)—which was deemed a treatment-related serious adverse event.